When Amy Cohen, 29, finished the New York City Marathon, she broke ground as the first person with the illness to run the 26.2 mile race Mass General Brigham Amy Cohen became the first-ever person ...

Aug 15 (Reuters) - In the latest setback for Pfizer's (PFE.N), opens new tab sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal in a late-stage trial for patients ...

The Department of Health and Human Services (HHS), Office of Minority Health requests that the National Academies of Sciences, Engineering, and Medicine convene an ad hoc committee to develop a ...

Cristina Pina receives funding from Children's Cancer and Leukaemia Group via the Little Princess Trust and the National Centre for the Replacement, Reduction and Refinement of Animals in Research.

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...

Sickle cell disease is a hereditary condition, which means a person inherits it from their biological parents. The condition occurs when a person inherits two copies of the hemoglobin beta (HBB) gene ...

This article is part of The Athletic’s series marking UK Black History Month. To view the whole collection, click here. Lassana Diarra was preparing for the 2010 World Cup in South Africa. The ...

After attending the first annual Global Sickle Cell Disease Congress in Accra, Ghana, in 2010, Obiageli Nnodu returned home to Nigeria with a deep resolve to combat the disease in her own country.

This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Sickle cell disease was ...